Caroline Wagner is a professor of public affairs at The Ohio State University. She receives funding from SECURE, a research security service funded by the National Science Foundat ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Our findings highlight divergent trends, such as the global reduction in tobacco-associated mortality but rising mortality linked to ambient particulate matter,” researchers wrote.

Scheduling radiotherapy in the morning may be beneficial for patients with nasopharyngeal carcinoma, but additional study is needed to confirm this finding, according to researchers. Obesity at ...

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

The ASIR (per 100,000 person-years) of testicular germ cell tumors increased from 4.71 in 1992 to 6.22 in 2021, for an average annual percent change (AAPC) of 0.92%. The ASIR of seminoma increased ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.